| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.9 |